Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer

Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer

Background Anti-PD-1(L1) therapies are less efficacious in patients with EGFR-mutated non-small-cell lung cancer. However, the underlying mechanism is poorly understood.Methods The characteristics of T cells in EGFR-mutated and wild-type tumors were analyzed based on The Cancer Genome Atlas database...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Lei Cheng, Caicun Zhou, Tao Jiang, Fei Zhou, Shengxiang Ren, Hongcheng Liu, Xinyu Liu, Xiaoxia Chen, Xuefei Li, Chao Zhao, Meng Qiao, Haowei Wang, Yijun Jia
Materialtyp:	Artikel
Språk:	English
Publicerad:	BMJ Publishing Group 2022-12-01
Serie:	Journal for ImmunoTherapy of Cancer
Länkar:	https://jitc.bmj.com/content/10/12/e005436.full

Liknande verk

Identification of clinically relevant subsets CD39+PD-1+CD8+ T cells and CD39+ regulatory T cells in intrahepatic cholangiocarcinoma using single-cell CyTOF
av: Qi-Wei Zhang, et al.
Publicerad: (2024-06-01)

CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer
av: Haowei Wang, et al.
Publicerad: (2024-12-01)

CD39 Expression identifies terminally exhausted CD8+ T cells
av: Gupta, P, et al.
Publicerad: (2015)

Targeting focal adhesion kinase boosts immune response in KRAS/LKB1 co-mutated lung adenocarcinoma via remodeling the tumor microenvironment
av: Meng Qiao, et al.
Publicerad: (2024-01-01)

The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
av: Liyun Lin, et al.
Publicerad: (2025-02-01)

EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer
av: Fei Ye BS, et al.
Publicerad: (2024-08-01)

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells
av: Elena Tassi, et al.
Publicerad: (2023-10-01)

T Cell-Derived Apoptotic Extracellular Vesicles Ameliorate Bone Loss via CD39 and CD73-Mediated ATP Hydrolysis
av: Yang X, et al.
Publicerad: (2025-01-01)

Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer
av: Pauline Weimer, et al.
Publicerad: (2022-03-01)

Combination of radiotherapy and PD-L1 blockade induces abscopal responses in EGFR-mutated lung cancer through activating CD8+ T cells
av: Wu-Yan Xia, et al.
Publicerad: (2024-10-01)

Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer
av: Kenro Tanoue, et al.
Publicerad: (2024-10-01)

Assessment of CD4<sup>+</sup> cells subpopulations with the expressing CD39 and CD73 ectonucleotidases in children with psoriasis
av: D. G. Kuptsova, et al.
Publicerad: (2022-07-01)

Dysfunctional subsets of CD39+ T cells, distinct from PD-1+, driven by leukemic extracellular vesicles in myeloid leukemias
av: Julian Swatler, et al.
Publicerad: (2022-11-01)

Cancer CD39 drives metabolic adaption and mal-differentiation of CD4+ T cells in patients with non-small-cell lung cancer
av: Ying Wang, et al.
Publicerad: (2023-12-01)

Circulating memory PD-1+CD8+ T cells and PD-1+CD8+T/PD-1+CD4+T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients
av: Jiang Liu, et al.
Publicerad: (2023-11-01)

Association between circulating CD39+CD8+ T cells pre-chemoradiotherapy and prognosis in patients with nasopharyngeal carcinoma
av: Dong, D-N, et al.
Publicerad: (2021)

CD39 expression by regulatory T cells participates in CD8+ T cell suppression during experimental Trypanosoma cruzi infection.
av: Cintia L Araujo Furlan, et al.
Publicerad: (2024-04-01)

<i>EGFR</i>-Mutant Lung Adenocarcinoma Cell-Derived Exosomal miR-651-5p Induces CD8+ T Cell Apoptosis via Downregulating BCL2 Expression
av: Chao Zhao, et al.
Publicerad: (2025-02-01)

Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma
av: Carsten Müller-Tidow, et al.
Publicerad: (2025-01-01)

CD39 is expressed by a wide range of cutaneous T‐cell lymphomas
av: Gilles Battesti, et al.
Publicerad: (2024-04-01)

Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer
av: Iwona Wertel, et al.
Publicerad: (2020-01-01)

Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer
av: Haowei Wang, et al.
Publicerad: (2025-02-01)

Letter to the Editor: EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer
av: Hinpetch Daungsupawong PhD, et al.
Publicerad: (2024-10-01)

Role of germinal center and CD39highCD73+ B cells in the age-related tonsillar involution
av: Rocío Pastor, et al.
Publicerad: (2024-04-01)

Immune cell expression patterns of CD39/CD73 ectonucleotidases in rodent models of cardiac arrest and resuscitation
av: Tomoaki Aoki, et al.
Publicerad: (2024-03-01)

CD80 Expressed by CD8+ T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8+ T Cells
av: Meagan R. Rollins, et al.
Publicerad: (2017-01-01)

CD161+CD127+CD8+ T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus
av: Jingjing Qu, et al.
Publicerad: (2024-12-01)

CD39 identifies a specific CD8 + T cell population in lung adenocarcinoma-related metastatic pleural effusion
av: Lei-lei Lv, et al.
Publicerad: (2023-12-01)

CD39 expression defines exhausted CD4+ T cells associated with poor survival and immune evasion in human gastric cancer
av: Zhen‐quan Duan, et al.
Publicerad: (2024-01-01)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
av: Hao Zhang, et al.
Publicerad: (2023-09-01)

Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
av: Mengdi Fu, et al.
Publicerad: (2025-02-01)

Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
av: Carla Fernanda Furtado Gardani, et al.
Publicerad: (2023-11-01)

Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4
av: Shaun Willimott, et al.
Publicerad: (2007-10-01)

Genomic correlates of the response to first-line PD-1 blockade plus chemotherapy in patients with advanced non-small-cell lung cancer
av: Tao Jiang, et al.
Publicerad: (2024-09-01)

CD39hi identifies an exhausted tumor-reactive CD8+ T cell population associated with tumor progression in human gastric cancer
av: Yang Shen, et al.
Publicerad: (2024-04-01)

CD39<sup>+</sup> EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME
av: I. V. Kudryavtsev, et al.
Publicerad: (2019-07-01)

CD39 molecule: a negative regulator expressed on T cells in patients with lung adenocarcinoma
av: Lu Tang, et al.
Publicerad: (2023-08-01)

CD39 Expression in Peripheral T Cells is Associated with Clinicopathological Characteristics in Patients with Cervical Cancer
av: Kuo Zhao, et al.
Publicerad: (2023-09-01)

EVALUATION OF THE CONTENT OF CD4+CD25+CD127LOW REGULATORY T CELLS AND THEIR FUNCTIONAL STATUS ACCORDING TO THE EXPRESSION OF CTLA-4 AND CD39 MOLECULES IN PATIENTS WITH RHEUMATOID ARTHRITIS
av: G. A. Zhulai, et al.
Publicerad: (2014-06-01)

Interleukin-7 activates human naive CD4+ cells and primes for interleukin-4 production.
av: Webb, L, et al.
Publicerad: (1997)